doi.org/10.1016/s2213-2600(20)30225-3

Original paper

Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy

Peter M. George

,

,

Richard O. Jenkins

The Lancet Respiratory Medicine32.80

Volume: 8, Issue: 8, Pages: 807 - 815

Published: Aug 1, 2020

Paper Fields

Paper Details

Title

Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy

DOI

doi.org/10.1016/s2213-2600(20)30225-3

Published Date

Aug 1, 2020

Journal

The Lancet Respiratory Medicine

Volume

8

Issue

8

Pages

807 - 815

Notes

History